摘要:
The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsteroidal anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.
摘要:
A high performance chiral selector having the formula: ##STR1## wherein Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 ring carbon atoms, either of which may be unsubstituted or substituted with one or more C.sub.1 to C.sub.6 alkyl, C.sub.1 to C.sub.6 alkoxy, NO.sub.2, N(R.sub.5).sub.3.sup.+, CN, COOR.sub.6 SO.sub.3 H and COR.sub.7 groups wherein R.sub.5, R.sub.6 and R.sub.7 are each independently hydrogen or C.sub.1 to C.sub.6 alkyl;R.sub.1 and R.sub.2 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl or phenyl;R.sub.3 and R.sub.4 are each independently C.sub.1 to C.sub.12 alkyl or C.sub.2 to C.sub.12 alkenyl; andm and n are each independently zero or 1, said compound being an R or an S enantiomer or a mixture of R and S enantiomers.
摘要:
A high performance chiral selector having the formula: ##STR1## wherein Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 ring carbon atoms, either of which may be unsubstituted or substituted with one or more C.sub.1 to C.sub.6 alkyl, C.sub.1 to C.sub.6 alkoxy, NO.sub.2, N(R.sub.5).sub.3.sup.+, CN, COOR.sub.6, SO.sub.3 H and COR.sub.7 groups wherein R.sub.5, R.sub.6 and R.sub.7 are each independently hydrogen or C.sub.1 to C.sub.6 alkyl;R.sub.1 and R.sub.2 ar each independently hydrogen, C.sub.1 to C.sub.6 alkyl or phenyl;R.sub.3 and R.sub.4 are each independently C.sub.1 to C.sub.12 alkyl or C.sub.2 to C.sub.12 alkenyl; andm and n are each independently zero or 1, said compound being an R or an S enantiomer or a mixture of R and S enantiomers.
摘要:
The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsterodial anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.
摘要:
Carbon clusters, such as C.sub.60 and C.sub.70 fullerenes are separated by means of a recognition selector having the formula: ##STR1## wherein R.sub.1 is ##STR2## wherein R.sub.2 is O, S or NR.sub.12 wherein R.sub.12 is independently hydrogen or P.dbd.O with the proviso that when R.sub.12 is P.dbd.O, then only one such group is present and all R.sub.2 's are additionally bonded to R.sub.12,R.sub.4 is independently O, S or NH,R.sub.3 and R.sub.5 are each independently hydrogen or lower alkyl,n and o are each independently zero, 1, 2 or 3,p, q, r, s and t are each independently zero or 1,Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 carbon atoms, either of which may be unsubstituted or substituted with one or more lower alkyl, NO.sub.2, N(R.sub.6).sub.3.sup.+, CN, COOR.sub.7, SO.sub.3 H, COR.sub.8 and OR.sub.9 wherein R.sub.6, R.sub.7, R.sub.8 and R.sub.9 are each independently hydrogen or lower alkyl;W is H or CH.dbd.CH.sub.2 ; andm is 1 to 10.
摘要:
Carbon clusters, such as C.sub.60 and C.sub.70 fullerenes are separated by means of a recognition selector having the formula: ##STR1## wherein R.sub.1 is ##STR2## wherein R.sub.2 is O, S or NR.sub.12 wherein R.sub.12 is independently hydrogen or P.dbd.O with the proviso that when R.sub.12 is P.dbd.O, then only one such group is present and all R.sub.2 's are additionally bonded to R.sub.12,R.sub.4 is independently O, S or NH,R.sub.3 and R.sub.5 are each independently hydrogen or lower alkyl,n and o are each independently zero, 1, 2 or 3,p, q, r, s and t are each independently zero or 1,Ar is a monocyclic or ortho-fused polycyclic aromatic moiety having up to 10 carbon atoms, either of which may be unsubstituted or substituted with one or more lower alkyl, NO.sub.2, N(R.sub.6).sub.3.sup.30, CN COOR.sub.7, SO.sub.3 H, COR.sub.8 and OR.sub.9 wherein R.sub.6, R.sub.7, R.sub.8 and R.sub.9 are each independently hydrogen or lower alkyl;W is H or CH.dbd.CH.sub.2 ; andm is 1 to 10.
摘要:
The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsterodial anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.
摘要:
The invention relates to a chiral selector useful in separating underivatized enantiomers of nonsterodial anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.
摘要:
Underivatized enantiomers of a beta -amino alcohol compound are directly separated by means of a chiral selector compound having the formula I wherein R2 and R3 are each independently lower alkyl, preferably methyl; R4 and R5 are each independently NO2, N(R6)3+, CN, COOR2, SO3H or COR8, preferably NO2; R6, R7 and R8 are each independently hydrogen or lower alkyl, preferably hydrogen or methyl, W is H or CH=CH2, X and Y are each independently OR9 or NR10R11, preferably X and Y are the same and most preferably X and Y are each OR9, or X and Y together with the P to which they are attached form a 5- or 6-membered ring having the formula R9, R10, R11 and R12 are each independently hydrogen or lower alkyl, R9 is preferably methyl, R10, R11 and R12 are preferably hydrogen or methyl, Z is O or NH, n is 1 to 20, preferably 1 to 8 when W is H, and 1 to 3 when W is CH=CH2, and m is 1 or 2, said compound being an R or an S enantiomer or a mixture of R and S enantiomers.
摘要翻译:β-氨基醇化合物的未衍生的对映异构体通过具有下式的手性选择化合物直接分离:其中R 2和R 3各自独立地为低级烷基,优选甲基; R 4和R 5各自独立地为NO 2,N(R 6)3+,CN,COOR 2,SO 3 H或COR 8,优选为NO 2; R 6,R 7和R 8各自独立地为氢或低级烷基,优选氢或甲基,W为H或CH = CH 2,X和Y各自独立地为OR 9或NR 10 R 11,优选X和Y为相同且最优选X和Y为 每个OR 9或X和Y与它们所连接的P一起形成具有下式的5-或6-元环:R 9,R 10,R 11和R 12各自独立地为氢或低级烷基,R 9优选为甲基 R 10,R 11和R 12优选为氢或甲基,Z为O或NH,当W为H时,n为1至20,优选1至8,W为CH = CH 2时为1至3,m为1或2 所述化合物是R或S对映体或R和S对映异构体的混合物。
摘要:
The present invention relates to the separation of .beta.-amino alcohol compounds, particularly compounds known as .beta.-blockers, by employing what is known as a chiral selector compound which can achieve separation of enantiomers without requiring derivatization of the enantiomers before effecting separation.